Cargando…

CYP2C19 genotype-directed P(2)Y(12) inhibitor antiplatelet therapy normalizes risk for major adverse cardiovascular events after percutaneous coronary intervention

OBJECTIVE: To study the use of CYP2C19 genotyping to guide P2Y(12) inhibitor selection to maximize efficacy, and attenuate risk in appropriate patients who underwent PCI for CAD. METHODS: We performed a retrospective analysis of 868 patients with CAD who received CYP2C19 genotyping after PCI and cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stys, Tomasz P., Gedela, Maheedhar, Gowda, Smitha N., Bares, Valerie, Fanta, Lauren, Petrasko, Marian, Hajek, Catherine, Larson, Eric, Stys, Adam T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322803/ https://www.ncbi.nlm.nih.gov/pubmed/34154743 http://dx.doi.org/10.1016/j.ihj.2021.03.004

Ejemplares similares

A prospective study of contrast preservation using ultra-low contrast delivery technique versus standard automated contrast injector system in coronary procedures
por: Stys, Adam, et al.
Publicado: (2019)

A Novel Technique of Stenting of the Renal Artery In-Stent Restenosis with GuideLiner® through Radial Approach
por: Gedela, Maheedhar, et al.
Publicado: (2017)

Bradycardia during Transradial Cardiac Catheterization due to Catheter Manipulation: Resolved by Catheter Removal
por: Gedela, Maheedhar, et al.
Publicado: (2017)

Complete Heart Block Causing Takotsubo Syndrome: A Case Report
por: Jasti, Jaswanth R, et al.
Publicado: (2022)

Novel Use of an Orbital Atherectomy Device for In-Stent Restenosis: Lessons Learned
por: Shaikh, K., et al.
Publicado: (2016)

Cardiovascular specialist 2025. Basics of training stay the same, logistics improve
por: Stys, Adam, et al.
Publicado: (2016)

Transcatheter tricuspid valve-in-valve implantation for very early bioprosthetic tricuspid stenosis secondary to pacemaker lead entrapment: a case report
por: Saad Shaukat, Muhammad Hamza, et al.
Publicado: (2022)

Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
por: Cavallari, Larisa H., et al.
Publicado: (2018)

CYP2C19 Genotype‐Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical Settings
por: Beitelshees, Amber L., et al.
Publicado: (2022)

CYP2C19 genotype-guided antiplatelet therapy: promises and pitfalls
por: Ellithi, Moataz, et al.
Publicado: (2020)

Lecture notes in numerical analysis with Mathematica
por: Styś, Tadeusz, et al.
Publicado: (2014)

Frequency Domain-optical Coherence Tomography of Coronary Arteries Using a Diluted Iodinated Contrast-saline Mix with 5-Fr Guide Catheters
por: Varga, Zoltan, et al.
Publicado: (2019)

Evaluating the Extent of Reusability of CYP2C19 Genotype Data among Patients Genotyped for Antiplatelet Therapy Selection
por: Beitelshees, Amber L., et al.
Publicado: (2020)

Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence
por: Gower, Megan N, et al.
Publicado: (2020)

Evaluation of race and ethnicity disparities in outcome studies of CYP2C19 genotype-guided antiplatelet therapy
por: Nguyen, Anh B., et al.
Publicado: (2022)

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
por: Ramesh, S., et al.
Publicado: (2020)

The Potential Environmental and Social Influence of the Inorganic Salt Hydrates Used as a Phase Change Material for Thermal Energy Storage in Solar Installations
por: Nartowska, Edyta, et al.
Publicado: (2023)

Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
por: Stys, Peter K.
Publicado: (2013)

The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack
por: McDermott, John H, et al.
Publicado: (2022)

CYP2D6 genotype and adverse events to risperidone in children and adolescents
por: Oshikoya, Kazeem A., et al.
Publicado: (2019)

Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis
por: Bauer, Tim, et al.
Publicado: (2011)

A new Xenicocephalus species from Ecuador (Heteroptera, Enicocephalomorpha, Enicocephalidae)
por: Štys, Pavel, et al.
Publicado: (2018)

Recent advances in understanding multiple sclerosis
por: Stys, Peter K., et al.
Publicado: (2019)

SLCO1B1*5 Allele Is Associated With Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine Care
por: Voora, Deepak, et al.
Publicado: (2022)

Cost-effectiveness of CYP2C19 genotyping to guide antiplatelet therapy for acute minor stroke and high-risk transient ischemic attack
por: Cai, Zeling, et al.
Publicado: (2021)

Personalized Antiplatelet Therapy Based on CYP2C19 Genotypes in Chinese ACS Patients Undergoing PCI: A Randomized Controlled Trial
por: Shi, Xiujin, et al.
Publicado: (2021)

Antiplatelet Therapy and Percutaneous Coronary Interventions
por: Davanzo, Rene Hameau, et al.
Publicado: (2021)

Frequency and Clinical Outcomes of CYP2C19 Genotype-Guided Escalation and De-escalation of Antiplatelet Therapy in a Real-World Clinical Setting
por: Martin, Jesse, et al.
Publicado: (2019)

Methodology for clinical genotyping of CYP2D6 and CYP2C19
por: Carvalho Henriques, Beatriz, et al.
Publicado: (2021)

Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
por: Al-Rubaish, Abdullah M., et al.
Publicado: (2020)

Molecular insights into the regulation of iron metabolism during the prenatal and early postnatal periods
por: Lipiński, Paweł, et al.
Publicado: (2012)

Detection of Avian Reoviruses in Wild Birds in Poland
por: Styś-Fijoł, Natalia, et al.
Publicado: (2017)

Influence of CYP2C19 Genotypes on the Occurrence of Adverse Drug Reactions of Voriconazole among Hematological Patients after Allo-HSCT
por: Sienkiewicz, Beata, et al.
Publicado: (2017)

Influence of CYP2C19*2/*17 genotype on adverse drug reactions of voriconazole in patients after allo-HSCT: a four-case report
por: Beata, Sienkiewicz, et al.
Publicado: (2017)

Correction: Methodology for clinical genotyping of CYP2D6 and CYP2C19
por: Henriques, Beatriz Carvalho, et al.
Publicado: (2022)

Takotsubo Cardiomyopathy: Typical and Atypical Variants, A Two-Year Retrospective Cohort Study
por: Murthy, Avinash, et al.
Publicado: (2014)

Intensity of antiplatelet therapy and percutaneous coronary intervention
por: Aronow, Wilbert S
Publicado: (2009)

Impact of Implementing CYP2C19 Genotype-Guided Antiplatelet Therapy on P2Y(12) Inhibitor Selection and Clinical Outcomes in Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention: A Real-World Study in China
por: Zhang, Yi, et al.
Publicado: (2021)

Estimation of Ion Competition via Correlated Responsivity Offset in Linear Ion Trap Mass Spectrometry Analysis: Theory and Practical Use in the Analysis of Cyanobacterial Hepatotoxin Microcystin-LR in Extracts of Food Additives
por: Urban, Jan, et al.
Publicado: (2013)

Quasi-spectral characterization of intracellular regions in bright-field light microscopy images
por: Lonhus, Kirill, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_17aspdpnt34s2s4h5q28u7scr4